| Compound Info | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAs | Base Info | ||||||||||
| ID | Cluster | Name | Target | MolWt | |||||||
|
NAs.003894 | 0 |
|
257.221 | |||||||
| Chemical Representations | |
|---|---|
| InChI | InChI=1S/C10H12FN3O4/c11-6-7-10(3-15,4-17-7)18-8(6)14-2-1-5(12)13-9(14)16/h1-2,6-8,15H,3-4H2,(H2,12,13,16)/t6-,7-,8+,10-/m0/s1 |
| InChI Key | OMDCCPKPEXOTMG-OORONAJNSA-N |
| SMILES | Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@@H]2F)c(=O)n1 |
| Molecular Formula | C10H12FN3O4 |
| Functional Fragments | ||
|---|---|---|
| Base | Ribose | Phosphate |
Match
|
Match
|
|
| Calculated Properties | ||
|---|---|---|
| logP | -1.178 | Computed by RDKit |
| Heavy Atom Count | 18 | Computed by RDKit |
| Ring Count | 3 | Computed by RDKit |
| Hydrogen Bond Acceptor Count | 7 | Computed by RDKit |
| Hydrogen Bond Donor Count | 2 | Computed by RDKit |
| Rotatable Bond Count | 2 | Computed by RDKit |
| Topological Polar Surface Area | 99.600 | Computed by RDKit |
| Activity Data | ||||||
|---|---|---|---|---|---|---|
| Target | Activity type | Relation | Value | Unit | Assay | Source |
| Hepatitis C virus | EC50 | > | 50000.0 | nM | Antiviral activity against HCV 1a infected in human HB-1 cells assessed as inhibition of viral RNA replication after 24 hrs | CHEMBL1208712 |
| ADMET | CC50 | > | 50000.0 | nM | Cytotoxicity against human HuH7 cells by MTS assay | CHEMBL1208712 |
| Deoxycytidine kinase | Kcat | = | 0.1221 | /s | Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells | CHEMBL1208712 |
| Deoxycytidine kinase | Km | = | 81100.0 | nM | Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells | CHEMBL1208712 |
| Deoxycytidine kinase | Kcat/Km | = | 1.5 | 10'-3/microM/s | Ratio of Kcat/Km for human recombinant deoxycytidine kinase | CHEMBL1208712 |
| UMP-CMP kinase | Activity | Activity at human recombinant UMP-CMP kinase | CHEMBL1208712 | |||